MYX · Mayne Pharma Group Ltd.
2.33
AUDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
AU$189.30M
PE
0.00
EV/EBITDA
7.3
DIV Yield
0%
Franking
100%
MQV Rating
5Very Weak
As at 23/06/2026 04:10:20 PM
Price Chart
Description
- All-Companies
- All-Consensus
- GROWTH AUS
- HALO Ords
Key Fundamentals
EPS 3 yr Growth
-65.30%
EBITDA Margin
11.20%
Operating Cashflow
$21m
Free Cash Flow Return
4.90%
ROIC
-20.90%
Interest Coverage
9.10
Quick Ratio
1.20
Performance
52 weeks range
Low 2.04 - 6.5
Trade Value (12mth)
AU$392,251.00
1 week
0.43%
1 month
-2.88%
YTD
-26.02%
1 year
-52.8%
All time high
37.10
Additional Data
Shares Outstanding (Fully Diluted)
81m
HALO Sector
Healthcare
Next Company Report Date
20-Aug-26
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
AUD
Short Sell (% of issue)
1.49
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Weak
Earnings
Very Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Strong
Valuation
News & Announcements
| Date | Event |
18 June 26ASXD | |
05 June 26ASXD | |
05 June 26ASXD | |
04 June 26ASXD | |
01 June 26ASXD |